In the latest quarter, 7 analysts provided ratings for Bio-Techne (NASDAQ:TECH), showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, ...
The FDA has granted Breakthrough Device Designation to Bio-Techne's (NASDAQ:TECH) ExoDx Prostate IntelliScore (EPI) test. Breakthrough Device status provides for more intensive guidance on development ...
(RTTNews) - Gemini Bioproducts, LLC, a supplier of cell culture reagents and process liquids and healthcare private equity firm BelHealth Investment Partners, LLC announced acquisition of selected ...
Gemini Bioproducts announced the acquisition of selected fetal bovine serum product rights and inventory from Bio-Techne (TECH). GeminiBio has a 39-year history of supporting FBS customers. With this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback